Skip to main content
. Author manuscript; available in PMC: 2015 May 6.
Published in final edited form as: Compr Physiol. 2013 Jul;3(3):1191–1212. doi: 10.1002/cphy.c120023

Figure 9.

Figure 9

FXR regulation of hepatic glucose metabolism. FXR signaling phosphorylates and inhibits glycogen synthase kinase 3β (GSK3β), which is an inhibitor of glycogen synthase activity. This results in stimulating glycogenesis. The FXR/SHP pathway inhibits PEPCK and glucose 6-phosphatase (G6Pase) to inhibit gluconeogenesis. This results in increasing glucose tolerance and insulin sensitivity.